How do we measure MRD in ALL and how should measurements affect decisions. Re: Treatment and prognosis?
Author:
Publisher
Elsevier BV
Subject
Clinical Biochemistry,Oncology
Reference66 articles.
1. Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95;Moricke;Blood,2008
2. Improved survival for children and adolescents with acute lymphoblastic leukemia between 1990 and 2005: a report from the children's oncology group;Hunger;J Clin Oncol,2012
3. Clinical significance of minimal residual disease quantification in adult patients with standard-risk acute lymphoblastic leukemia;Bruggemann;Blood,2006
4. Minimal residual disease diagnostics in acute lymphoblastic leukemia: need for sensitive, fast, and standardized technologies;van Dongen;Blood,2015
5. Prognostic significance of minimal residual disease in high risk B-ALL: a report from Children's Oncology Group study AALL0232;Borowitz;Blood,2015
Cited by 28 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Flow cytometric and cytomorphological definition of remission achievement in children with B-lineage acute lymphoblastic leukemia;Pediatric Hematology/Oncology and Immunopathology;2023-12-20
2. A Single Dose of PEG-Asparaginase at the Beginning of Induction Not Only Accelerates MRD Clearance but Also Improves Long-Term Outcome in Children with B-Lineage ALL;Cancers;2023-11-23
3. Updates on lymphoblastic leukemia/lymphoma classification and minimal/measurable residual disease analysis;Seminars in Diagnostic Pathology;2023-11
4. Concordance of Next-Generation Sequencing and Multiparametric Flow Cytometry Methods for Detecting Measurable Residual Disease in Adult Acute Lymphoblastic Leukemia: Optimizing Prediction of Clinical Outcomes From a Single-Center Study;Clinical Lymphoma Myeloma and Leukemia;2023-11
5. Minimal residual disease monitoring in B-lineage acute lymphoblastic leukemia using flow cytometry. Guidelines of the Russian-Belarusian multicenter group for pediatric acute leukemia studies;Pediatric Hematology/Oncology and Immunopathology;2023-10-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3